NO903542D0 - Frysetoerket blanding og fremgangsmaate for oral administrering av legemidler, naeringsmidler og biologisk aktive materialer. - Google Patents

Frysetoerket blanding og fremgangsmaate for oral administrering av legemidler, naeringsmidler og biologisk aktive materialer.

Info

Publication number
NO903542D0
NO903542D0 NO1990903542A NO903542A NO903542D0 NO 903542 D0 NO903542 D0 NO 903542D0 NO 1990903542 A NO1990903542 A NO 1990903542A NO 903542 A NO903542 A NO 903542A NO 903542 D0 NO903542 D0 NO 903542D0
Authority
NO
Norway
Prior art keywords
foodstuffs
pharmaceuticals
freeze
procedure
oral administration
Prior art date
Application number
NO1990903542A
Other languages
English (en)
Other versions
NO300085B1 (no
NO903542L (no
Inventor
Bernard Ecanow
Original Assignee
Medaphore Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27014357&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO903542(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/393,582 external-priority patent/US5039540A/en
Application filed by Medaphore Inc filed Critical Medaphore Inc
Publication of NO903542D0 publication Critical patent/NO903542D0/no
Publication of NO903542L publication Critical patent/NO903542L/no
Priority to NO965460A priority Critical patent/NO302557B1/no
Publication of NO300085B1 publication Critical patent/NO300085B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C1/00—Concentration, evaporation or drying
    • A23C1/06—Concentration by freezing out the water
    • A23C1/08—Freeze-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Freezing, Cooling And Drying Of Foods (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
NO903542A 1989-08-14 1990-08-13 Lett opplöselig bærermateriale for oral administrering av f.eks. legemidler, næringsmidler og biologisk aktive materialer samt fremgangsmåte for fremstilling av et slikt bærermateriale NO300085B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO965460A NO302557B1 (no) 1989-08-14 1996-12-18 Fremgangsmåte for fremstilling av et lett opplösbart bærermateriale for administrering av aktive materialer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/393,582 US5039540A (en) 1989-08-14 1989-08-14 Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US07/513,601 US5079018A (en) 1989-08-14 1990-04-30 Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs

Publications (3)

Publication Number Publication Date
NO903542D0 true NO903542D0 (no) 1990-08-13
NO903542L NO903542L (no) 1991-02-15
NO300085B1 NO300085B1 (no) 1997-04-07

Family

ID=27014357

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903542A NO300085B1 (no) 1989-08-14 1990-08-13 Lett opplöselig bærermateriale for oral administrering av f.eks. legemidler, næringsmidler og biologisk aktive materialer samt fremgangsmåte for fremstilling av et slikt bærermateriale

Country Status (8)

Country Link
US (1) US5079018A (no)
EP (1) EP0450141B2 (no)
JP (1) JP3303884B2 (no)
CY (1) CY1923A (no)
DE (1) DE69019817T3 (no)
DK (1) DK0450141T4 (no)
HK (1) HK118096A (no)
NO (1) NO300085B1 (no)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5744500A (en) * 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5275369A (en) * 1991-01-31 1994-01-04 Ohi Seisakusho Co., Ltd. Protective cover for seat sliding devices
WO1993012769A1 (en) * 1991-12-24 1993-07-08 Yamanouchi Pharmaceutical Co., Ltd. Intrabuccally disintegrating preparation and production thereof
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
EP0621777B1 (de) * 1992-01-17 1996-09-11 ALFATEC-PHARMA GmbH Wirkstoff-enthaltende festkörper mit einem gerüst aus hydrophilen makromolekülen und verfahren zu ihrer herstellung
US5876754A (en) * 1992-01-17 1999-03-02 Alfatec-Pharma Gmbh Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
JP3069458B2 (ja) * 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
US5221545A (en) * 1992-03-09 1993-06-22 Abbott Laboratories Method of providing selenium in a nutritional product
US5242143A (en) * 1992-03-12 1993-09-07 Tachi-S Co. Ltd. Cover for slide rail of automotive seat
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
IL105553A (en) 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
US20070117863A1 (en) * 1993-02-22 2007-05-24 Desai Neil P Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US20030073642A1 (en) * 1993-02-22 2003-04-17 American Bioscience, Inc. Methods and formulations for delivery of pharmacologically active agents
US20030068362A1 (en) * 1993-02-22 2003-04-10 American Bioscience, Inc. Methods and formulations for the delivery of pharmacologically active agents
US20030133955A1 (en) * 1993-02-22 2003-07-17 American Bioscience, Inc. Methods and compositions useful for administration of chemotherapeutic agents
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
US5457895A (en) * 1993-10-01 1995-10-17 R. P. Scherer Corporation Method of identifying freeze-dried dosage forms
US5382437A (en) * 1993-10-25 1995-01-17 Hunter Research Corporation Frozen liquified gas composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
ATE215106T1 (de) * 1993-12-01 2002-04-15 Bioartificial Gel Technologies Inc Hydrogel auf basis von albumin
WO1996003978A1 (en) * 1994-08-04 1996-02-15 Quadrant Holdings Cambridge Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US5837287A (en) * 1994-10-28 1998-11-17 R P Scherer Corporation Process for preparing solid pharmaceutical dosage forms
CA2134611C (en) * 1994-10-28 2002-12-24 Richard John Yarwood Process for preparing solid pharmaceutical dosage forms
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
CA2214026C (en) * 1995-03-02 2007-10-16 R.P. Scherer Limited Pharmaceutical compositions comprising monoamine oxidase b inhibitors
GB9504201D0 (en) 1995-03-02 1995-04-19 Scherer Ltd R P Process for the preparation of a solid pharmaceutical dosage form
EG23659A (en) 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US6455068B1 (en) 1995-12-26 2002-09-24 Onesta Nutrition, Inc. Dietary fiber delivery system
US5686133A (en) * 1996-01-31 1997-11-11 Port Systems, L.L.C. Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
US6509146B1 (en) 1996-05-29 2003-01-21 Universal Preservation Technologies, Inc. Scalable long-term shelf preservation of sensitive biological solutions and suspensions
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US8137684B2 (en) 1996-10-01 2012-03-20 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
GB9621614D0 (en) * 1996-10-17 1996-12-11 Cultech Limited Vitamin delivery
GB9702799D0 (en) * 1997-02-12 1997-04-02 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
US20030004170A1 (en) * 1997-05-19 2003-01-02 Zonagen, Inc. Combination therapy for modulating the human sexual response
EP1023050B1 (en) * 1997-06-27 2013-09-25 Abraxis BioScience, LLC Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US20030199425A1 (en) * 1997-06-27 2003-10-23 Desai Neil P. Compositions and methods for treatment of hyperplasia
DE19739031A1 (de) * 1997-09-05 1999-03-11 Suwelack Nachf Dr Otto Mittel zur peroralen Verabreichung, seine Herstellung und Verwendung
TW527195B (en) 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
US20040265377A1 (en) * 1997-10-27 2004-12-30 Harry Seager Solid dispersing vaccine composition for oral delivery
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
EP1100549B1 (en) * 1998-07-30 2007-03-07 Point Biomedical Corporation A novel excipient for the lyophilization of aqueous suspensions of microparticles
US20030092652A1 (en) * 1998-08-14 2003-05-15 Maria Bruno Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
EP1104309B8 (en) 1998-08-14 2006-07-05 Valentis Inc. Co-lyophilized complex comprising a nucleic acid vector and a formulating agent
US6482426B1 (en) 1998-09-17 2002-11-19 Zonagen, Inc. Compositions for the treatment of male erectile dysfunction
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
US6680071B1 (en) 1999-03-03 2004-01-20 R. P. Scherer Technologies, Inc. Opioid agonist in a fast dispersing dosage form
US6090401A (en) * 1999-03-31 2000-07-18 Mcneil-Ppc, Inc. Stable foam composition
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
DE19931708A1 (de) 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
DE10032456A1 (de) 2000-07-04 2002-01-31 Lohmann Therapie Syst Lts Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen
US6451328B1 (en) * 2000-08-03 2002-09-17 Color Access, Inc. Antioxidants in clusters of structured water
GB0102691D0 (en) 2001-02-02 2001-03-21 Nestle Sa Water soluable powders and tablets
US6588180B2 (en) 2001-02-02 2003-07-08 R. P. Scherer Technologies, Inc. Constricted neck blister pack and apparatus and method for making the same
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US7122057B2 (en) 2001-04-12 2006-10-17 Therics, Llc Method and apparatus for engineered regenerative biostructures such as hydroxyapatite substrates for bone healing applications
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
ATE376020T1 (de) 2001-08-22 2007-11-15 Bioartificial Gel Technologies Inc Verfahren zu herstellung von aktivierten polyethylenglykolen
US9358214B2 (en) * 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US20030175370A1 (en) * 2002-03-07 2003-09-18 Carrington Laboratories, Inc. Dispersed solid-containing complex carbohydrate
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
DE10251963A1 (de) * 2002-11-08 2004-05-19 Lts Lohmann Therapie-Systeme Ag Transmucosale pharmazeutische Darreichungsform
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
ES2341443T3 (es) * 2002-12-04 2010-06-21 Mitsui Chemicals Agro, Inc. Metodo preventivo de contaminacion micotoxica en cereales.
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
US7351787B2 (en) * 2004-03-05 2008-04-01 Bioartificial Gel Technologies, Inc. Process for the preparation of activated polyethylene glycols
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ709754A (en) * 2004-10-21 2017-02-24 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
CA2636026A1 (en) * 2006-01-20 2007-07-26 Monosol Rx, Llc Film lined pouch and method of manufacturing this pouch
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
AU2007328373A1 (en) * 2006-12-01 2008-06-12 Cima Labs Inc. Oral transmucosal nicotine dosage form
US20090214442A1 (en) * 2006-12-01 2009-08-27 Cephalon, Inc. Oral Transmucosal Nicotine Dosage Form
TW200904340A (en) 2007-05-11 2009-02-01 Mannatech Inc Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
DE102009005865A1 (de) * 2009-01-07 2010-07-08 Klosterfrau Berlin Gmbh Dosiereinheit und Zusammensetzung zur Behandlung von entzündlichen Erkrankungen des Mund- und Rachenraums
GB0900473D0 (en) 2009-01-13 2009-02-11 Univ Gent Aqueous coacervate compositions suitable for making powders and water-soluble formulations of biologically-active agents
TWI468157B (zh) * 2009-04-29 2015-01-11 Intervet Int Bv 形成錠劑的方法，進行該方法的系統及包含該錠劑的包裝物
TWI471127B (zh) * 2009-04-29 2015-02-01 Intervet Int Bv 供人類使用之口服崩解錠劑的製備方法、所製得之口服崩解錠劑、以及含有該口服崩解錠劑的包裝物
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
UY33173A (no) * 2010-01-08 2011-07-29 Eurand Inc
US10548839B2 (en) 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
US9956169B2 (en) * 2010-10-08 2018-05-01 R.P. Scherer Technologies, Llc Oral vaccine fast-dissolving dosage form using starch
DE102010048408A1 (de) 2010-10-15 2012-04-19 Lts Lohmann Therapie-Systeme Ag Laminat mit verbessertem Wasserretentionsverhalten
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
WO2012075455A2 (en) 2010-12-02 2012-06-07 Aptalis Pharmatech, Inc. Rapidly dispersing granules, orally disintegrating tablets and methods
US20140072671A1 (en) * 2012-06-29 2014-03-13 Adam Auerbach Multi-component oral delivery systems and uses thereof
KR20190005199A (ko) 2016-05-05 2019-01-15 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
DE102017112527B4 (de) 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
DE102017127434A1 (de) 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Taschenförmige oral auflösende Filme mit hoher Wirkstoffbeladung
KR102076829B1 (ko) * 2018-11-30 2020-02-12 인하대학교 산학협력단 친환경 전자파 차폐재 조성물의 제조방법
KR102076833B1 (ko) * 2018-11-30 2020-02-12 인하대학교 산학협력단 탄소 소재를 포함한 환경 친화적 전자파 차폐재 조성물의 제조방법
DE102019100483A1 (de) 2019-01-10 2020-07-16 Lts Lohmann Therapie-Systeme Ag Oraler Dünnfilm
AU2020310953A1 (en) * 2019-07-09 2022-02-17 Aquero Canada Ltd. Compositions, processes of production, sterilization, and health-promoting uses of lyophilized milk
KR102541470B1 (ko) * 2020-11-23 2023-06-07 주식회사 유에이치에스 버섯 유래 키토산을 이용한 가축 및 반려동물용 음수첨가제 및 이의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US473331A (en) * 1892-04-19 Andrew davidson mckay
US2166074A (en) * 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
JPS5017359A (no) * 1973-06-19 1975-02-24
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
US4343797A (en) * 1981-01-05 1982-08-10 Ecanow Charles S Synthetic whole blood and a method of making the same
ATE24964T1 (de) * 1981-12-11 1987-01-15 Wyeth John & Brother Ltd Verfahren zur herstellung von festen formgegenstaenden.
US4539204A (en) * 1982-10-29 1985-09-03 Neomed Inc. Gelatin based synthetic blood and a method of making the same
US4596788A (en) * 1983-02-07 1986-06-24 Neomed, Inc. Gelatin and lecithin based synthetic whole blood and a method of making the same
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
US4752466A (en) * 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol

Also Published As

Publication number Publication date
EP0450141A1 (en) 1991-10-09
NO300085B1 (no) 1997-04-07
EP0450141B1 (en) 1995-05-31
JPH0386837A (ja) 1991-04-11
DE69019817D1 (de) 1995-07-06
NO903542L (no) 1991-02-15
CY1923A (en) 1997-03-07
DK0450141T3 (da) 1995-07-24
US5079018A (en) 1992-01-07
EP0450141B2 (en) 1999-03-24
DE69019817T2 (de) 1995-10-05
DK0450141T4 (da) 2000-12-18
HK118096A (en) 1996-07-12
JP3303884B2 (ja) 2002-07-22
DE69019817T3 (de) 1999-06-17

Similar Documents

Publication Publication Date Title
NO903542L (no) Frysetoerket blanding og fremgangsmaate for oral administrering av legemidler, naeringsmidler og biologisk aktive materialer.
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
NO912643L (no) Fremgangsmaate for fremstilling av et toert, partikkelformig utleveringssystem for farmasoeytiske preparater og konfektprodukter.
DE69011059T2 (de) Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen.
NO871791L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende syrelabile stoffer for oral anvendelse.
DE3780223T2 (de) Arzneimittel mit gesteuerter freisetzung.
FI943570A (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
NL300045I2 (nl) Fluorcytidine-derivaten, de bereiding daarvan en geneesmiddelen die deze derivaten bevatten.
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
NO901430L (no) Fremgangsmaate til fremstilling av 4(3h)-pteridioner, og medikamenter inneholdende slike.
IT8820073A0 (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
DE3685604T2 (de) 1,7-naphthyridinderivate und diese enthaltende arzneimittel.
DE3481125D1 (de) Pheophorbidderivate und diese enthaltende pharmazeutische mittel.
NO883465L (no) Fremgangsmaate og mellomprodukter for fremstilling av 1-fenyl-3-(1-piperazinyl)-1h-indazoler, og anvendelse derav som medikamenter.
DE3874390D1 (de) Carboxystyrol-derivate und arzneimittel, die sie als wirkstoff enthalten.
DE69018914D1 (de) Pharmakologisch aktive Präparate und sie enthaltende Arzneimittel.
DK578589D0 (da) Farmaceutisk praeparat indeholdende labdanterpenoidderivater og pyrimido(6,1-a)isoquinolin-4-onderivater, dets fremstilling og anvendelse
DE3761561D1 (de) N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen.
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
NO893291D0 (no) Fremgangsmaate for fremstilling av nye benzasolderivater og farmasoeytiske preparater derav.
DE3577202D1 (de) Hexahydroindolizinverbindungen, pharmazeutische zubereitungen, methode und zwischenprodukte.
DE3781357D1 (de) 5-fluorouracil-derivate, pharmazeutische zubereitung und verwendung.
IT1216894B (it) Composizione farmaceutica eprocedimento per la sua preparazione.
DE3764233D1 (de) Cyclopentylaether, deren herstellung und pharmazeutische formulierung.

Legal Events

Date Code Title Description
MK1K Patent expired